Literature DB >> 1824458

Solitary blood cultures as a quality assurance indicator.

R B Schifman1, C L Strand, E Braun, A Louis-Charles, R P Spark, M L Fried.   

Abstract

For patients with suspected bacteremia, at least two separate blood cultures are recommended to achieve maximum sensitivity and to properly interpret results. Since a single blood collection may signify an improper procedure with serious consequences if the diagnosis of blood stream infection is missed, we investigated this problem with studies at three teaching hospitals (A, B, and C) and by a survey of 38 other hospitals. The incidence of solitary blood cultures ranged from 1 to 99% (median 26%) at the surveyed institutions. Among the cases investigated at hospitals B and C, between 10 and 30% of solitary blood cultures were not clinically indicated, while most of the others were caused by the physician not knowing that one culture was insufficient or by failure to complete the diagnostic plan. Focused concurrent intervention at hospital B was associated with reductions in solitary blood cultures from 40.0 to 24.6% (p = 0.045) and a decline in those not indicated from 38.1 to 12.5% (p = 0.192). Global educational efforts at hospital A were associated with a decrease in solitary blood culture rates from 52 to 37% (p = 0.016). These results show that blood culture practice varies widely among institutions in spite of consensus recommendations for proper specimen collections. We estimate that, nationwide, up to 18,000 etiologic diagnoses of bacteremia are missed annually because of this problem. Monitoring institutional solitary blood cultures is recommended as a test utilization indicator and as the basis for improving blood culture practice.

Entities:  

Mesh:

Year:  1991        PMID: 1824458     DOI: 10.1177/0885713x9100600406

Source DB:  PubMed          Journal:  Qual Assur Util Rev        ISSN: 0885-713X


  7 in total

1.  Species-driven interpretation guidelines in case of a single-sampling strategy for blood culture.

Authors:  D Leyssene; S Gardes; P Vilquin; J-P Flandrois; G Carret; B Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

2.  Blood culture contamination in Tanzania, Malawi, and the United States: a microbiological tale of three cities.

Authors:  Lennox K Archibald; Kisali Pallangyo; Peter Kazembe; L Barth Reller
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

Review 3.  Evolving approaches to management of quality in clinical microbiology.

Authors:  R C Bartlett; M Mazens-Sullivan; J Z Tetreault; S Lobel; J Nivard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

Review 4.  How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art.

Authors:  Brigitte Lamy; Sylvie Dargère; Maiken C Arendrup; Jean-Jacques Parienti; Pierre Tattevin
Journal:  Front Microbiol       Date:  2016-05-12       Impact factor: 5.640

5.  Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods.

Authors:  Marc Vasse; Eric Farfour; Gauthier Péan de Ponfilly; Julie Lourtet-Hascoet; Huong Porcheret; Emmanuelle Cambau; Alban Le Monnier; Hervé Jacquier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-23       Impact factor: 3.267

6.  Bloodstream infections, antibiotic resistance and the practice of blood culture sampling in Germany: study design of a Thuringia-wide prospective population-based study (AlertsNet).

Authors:  André Karch; Roland P Schmitz; Florian Rißner; Stefanie Castell; Sandra Töpel; Matthias Jakob; Frank M Brunkhorst; Rafael T Mikolajczyk
Journal:  BMJ Open       Date:  2015-12-15       Impact factor: 2.692

7.  The Association between the Establishment of a General Internal Medicine Department and an Increased Number of Blood Cultures in Other Departments: An Interrupted Time Series Analysis.

Authors:  Tatsuya Aoki; Hajime Yamazaki; Tadayuki Hashimoto; Ryosuke Horitani; Shunichi Fukuhara
Journal:  Intern Med       Date:  2021-06-19       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.